These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14558029)

  • 21. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell-free DNA.
    Johnson J; Pastuck M; Metcalfe A; Connors G; Krause R; Wilson D; Cuckle H
    Prenat Diagn; 2013 Nov; 33(11):1044-9. PubMed ID: 23836291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice.
    Stenhouse EJ; Crossley JA; Aitken DA; Brogan K; Cameron AD; Connor JM
    Prenat Diagn; 2004 Oct; 24(10):774-80. PubMed ID: 15503268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of first-trimester contingent screening strategies for Down syndrome.
    Sahota DS; Leung TY; Chan LW; Law LW; Fung TY; Chen M; Lau TK
    Ultrasound Obstet Gynecol; 2010 Mar; 35(3):286-91. PubMed ID: 20052660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Between pregnancy biological variability of first trimester markers of Down syndrome: implications for screening in subsequent pregnancies.
    Spencer K
    Prenat Diagn; 2001 Jun; 21(6):445-7. PubMed ID: 11438946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal serum screening for Down syndrome in the first trimester: experience from Belarus.
    Tsukerman GL; Gusina NB; Cuckle HS
    Prenat Diagn; 1999 Jun; 19(6):499-504. PubMed ID: 10416962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies.
    Avgidou K; Papageorghiou A; Bindra R; Spencer K; Nicolaides KH
    Am J Obstet Gynecol; 2005 Jun; 192(6):1761-7. PubMed ID: 15970804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early vaginal bleeding and first-trimester markers for Down syndrome.
    De Biasio P; Canini S; Crovo A; Prefumo F; Venturini PL
    Prenat Diagn; 2003 Jun; 23(6):470-3. PubMed ID: 12813760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observational study comparing the performance of first-trimester screening protocols for detecting trisomy 21 in a North Indian population.
    Kaul A; Singh C; Gupta R; Arora N; Gupta A
    Int J Gynaecol Obstet; 2017 Apr; 137(1):14-19. PubMed ID: 28099747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of a programme for the prenatal screening for Down's syndrome by ultrasonographic nuchal translucency measurement and serum determinations in the first trimester of pregnancy].
    Go AT; Hupkes HW; Lomecky M; Twisk J; Blankenstein JM; van Vugt JM
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2795-9. PubMed ID: 16385832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contingent screening for Down syndrome completed in the first trimester: a multicenter study.
    Muñoz-Cortes M; Arigita M; Falguera G; Seres A; Guix D; Baldrich E; Acera A; Torrent A; Rodriguez-Veret A; Lopez-Quesada E; Garcia-Moreno R; Gonce A; Borobio V; Borrell A
    Ultrasound Obstet Gynecol; 2012 Apr; 39(4):396-400. PubMed ID: 21674658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome.
    Kadir RA; Economides DL
    Ultrasound Obstet Gynecol; 1997 Apr; 9(4):244-7. PubMed ID: 9168574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for Down's syndrome in the first trimester: combined risk calculation, methodology, and validation of a web-based system.
    Kublickas M; Crossley J; Aitken D
    Acta Obstet Gynecol Scand; 2009; 88(6):635-8, 7p following 638. PubMed ID: 19330568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.
    Wald NJ; Hackshaw AK
    Prenat Diagn; 1997 Sep; 17(9):821-9. PubMed ID: 9316126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: a happy union?
    Thilaganathan B
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):229-30. PubMed ID: 10341398
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnosis of trisomy 21: nuchal translucency and/or serum markers?].
    Audibert F; Dommergues M; Benattar C; Taieb J; Champagne C; Frydman R
    Gynecol Obstet Fertil; 2001 Sep; 29(9):599-604. PubMed ID: 11680948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender impact on first trimester markers in Down syndrome screening.
    Larsen SO; Wøjdemann KR; Shalmi AC; Sundberg K; Christiansen M; Tabor A
    Prenat Diagn; 2002 Dec; 22(13):1207-8. PubMed ID: 12478634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.